Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.94 Analyst target: $5.97 Upside: 207.73%
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company is headquartered in Princeton, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.